Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
52-week range
$12.30 – $15.30
40% from low
Click rows below (any statement) to add/remove series. Selection stays as you switch tabs.
| 2020 | 2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|---|
| Revenue | $199.9K | $0 | $0 | $0 | $0 | $16.8M |
| Cost of revenue | $138.6K | $209.0K | $391.7K | $2.6M | $0 | $0 |
| Gross profit | $61.3K | −$209.0K | −$391.7K | −$2.6M | $0 | $0 |
| Gross margin | 30.7% | — | — | — | — | 0.0% |
| R&D | $138.6K | $209.0K | $391.7K | $2.6M | $1.2M | $1.2M |
| Operating income | −$1.4M | −$839.0K | −$2.3M | −$6.9M | −$7.6M | $0 |
| EBITDA | $0 | $0 | −$1.6M | −$6.9M | −$7.6M | $2.3M |
| Net income | −$660.6K | −$595.4K | −$2.5M | −$7.4M | −$8.0M | −$43.3M |
| Net margin | -330.4% | — | — | — | — | -257.9% |
| EPS (diluted) | -0.11 | -0.10 | -0.43 | -1.28 | -1.43 | -23.04 |
Annual figures · source: Financial Modeling Prep
No one on the platform currently holds CHRO.
No tracked institution reports a position in CHRO as of their last filing.
| Execution date | Ratio |
|---|---|
| 2025-07-02 | 1-for-10reverse |
No one on the platform has traded CHRO yet.
| $9M |
| — |
| IMVIFIMV Inc. | $0.00 | +0.00% | $23423 | — |
| OBSVObsEva S.A. | $0.10 | +0.00% | $11M | — |
Source: Financial Modeling Prep · peers by sector/industry
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.